companydata.dkcompanydata.dk

CHEMVET PHARMA ApS: Financial statements 2025

CVR: 20386908

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

CHEMVET PHARMA ApS (CVR 20386908) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,700,759 and a net result of DKK 970,939 compared with DKK 807,613 the year before. That is an increase of 16.1% compared with the year before. Equity in the 2025 report amounted to DKK 3,822,846. The solvency ratio was 66%. The company had 1 employee in the financial year.

Gross Profit
DKK 1,700,759
Profit/Loss
DKK 970,939
Equity
DKK 3,822,846
Total Assets
DKK 5,791,907
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-1.7M971K3.8M1
2024-1.5M808K3.1M1
2023-892K517K2.3M1
2022-251K-312K1.8M2
2021-317K-477K2.1M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CHEMVET PHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Frank Arvé Christensen joins the board of CHEMVET PHARMA ApSDec 1, 2025

As of December 1, 2025, Frank Arvé Christensen has joined the board of directors of CHEMVET PHARMA ApS.

Sarah Arvé joins the board of CHEMVET PHARMA ApSDec 1, 2025

As of December 1, 2025, Sarah Arvé has joined the board of directors of CHEMVET PHARMA ApS.

Peter Arvé Christensen leaves the board of CHEMVET PHARMA ApSDec 1, 2025

As of December 1, 2025, Peter Arvé Christensen has left the board of directors of CHEMVET PHARMA ApS.

Frank Arvé Christensen joins CHEMVET PHARMA ApS as directorDec 1, 2025

As of December 1, 2025, Frank Arvé Christensen is registered as director of CHEMVET PHARMA ApS.

Peter Arvé Christensen steps down as director of CHEMVET PHARMA ApSDec 1, 2025

As of December 1, 2025, Peter Arvé Christensen has stepped down as director of CHEMVET PHARMA ApS.

Frank Arvé Christensen leaves the board of CHEMVET PHARMA ApSNov 30, 2025

As of November 30, 2025, Frank Arvé Christensen has left the board of directors of CHEMVET PHARMA ApS.

Sarah Arvé leaves the board of CHEMVET PHARMA ApSNov 30, 2025

As of November 30, 2025, Sarah Arvé has left the board of directors of CHEMVET PHARMA ApS.

CHEMVET PHARMA ApS: The 2024 annual report is outJun 27, 2025

CHEMVET PHARMA ApS has published its annual report for 2024. Gross profit came to DKK 1,464,494, and the net result was DKK 807,613.

About CHEMVET PHARMA ApS

CHEMVET PHARMA ApS is a Danish company of the type Anpartsselskab based in Silkeborg, founded in 1997. The company is registered under the industry Engroshandel med andre fødevarer. The company was previously named ApS KBIL 9 NR. 2027. The management consists of Frank Arvé Christensen. The board consists of Sarah Arvé (chair), Frank Arvé Christensen and Maria Arvé Brostrøm. The company is owned by Frank Arvé Christensen, Sarah Arvé and Maria Arvé Brostrøm. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 1,700,759 and a net result of DKK 970,939 compared with DKK 807,613 the year before. Equity in the 2025 report amounted to DKK 3,822,846.

Source: annual report 2025, Danish Business Authority